Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any preeclampsia in which the cause of the disease is a mutation in the CORIN gene.
CORIN encodes corin, serine peptidase (1,042 aa). Serine-type endopeptidase involved in atrial natriuretic peptide (NPPA) and brain natriuretic peptide (NPPB) processing. Highest expression in Heart Atrial Appendage (27.7 TPM) and Heart Left Ventricle (10.0 TPM).
Preeclampsia/eclampsia 5 is associated with mutations in the CORIN gene on chromosome 4.
The CORIN protein participates in CORIN(802-1042) hydrolyses NPPA to form NPPA(124-151) pathway.
CORIN is classified as a druggable target (Cell Surface, Druggable Genome, Enzyme, and Protease categories) with score 0.0.
Genetic testing for CORIN is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for preeclampsia/eclampsia 5 has been reported in the published literature.
No clinical trials have been registered for preeclampsia/eclampsia 5.
92 publications have been identified in PubMed for preeclampsia/eclampsia 5. Research spans Epidemiology / Natural History (47%), Clinical Trial Publication (24%), and Review / Meta-Analysis (11%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 43 | 47% |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 1:48 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Clinical study results
22 |
24% |
Research summaries | 10 | 11% |
Laboratory research | 8 | 9% |
Patient case studies | 5 | 5% |
Testing and diagnosis research | 3 | 3% |
Other research | 1 | 1% |
Alinia T (2026). [PMID: 42069593](https://pubmed.ncbi.nlm.nih.gov/42069593/). *Int J Equity Health*. [Epidemiology / Natural History]
Phelps AJD (2026). [PMID: 41648074](https://pubmed.ncbi.nlm.nih.gov/41648074/). *Pregnancy (Hoboken, N.J.)*. [Epidemiology / Natural History]
Kwak S (2026). [PMID: 41627823](https://pubmed.ncbi.nlm.nih.gov/41627823/). *JAMA internal medicine*. [Clinical Trial Publication]
Saffold K (2026). [PMID: 42083975](https://pubmed.ncbi.nlm.nih.gov/42083975/). *Am J Physiol Heart Circ Physiol*. [Basic Science / Preclinical]
Chung D (2026). [PMID: 41833554](https://pubmed.ncbi.nlm.nih.gov/41833554/). *International journal of stroke : official journal of the International Stroke Society*. [Epidemiology / Natural History]
Michnick AI (2026). [PMID: 42012833](https://pubmed.ncbi.nlm.nih.gov/42012833/). *JAMA Netw Open*. [Clinical Trial Publication]
Palakodeti S (2026). [PMID: 41802530](https://pubmed.ncbi.nlm.nih.gov/41802530/). *Am J Cardiol*. [Epidemiology / Natural History]
Cheng V (2026). [PMID: 41780201](https://pubmed.ncbi.nlm.nih.gov/41780201/). *Journal of autoimmunity*. [Epidemiology / Natural History]
Agrawal R (2026). [PMID: 41918633](https://pubmed.ncbi.nlm.nih.gov/41918633/). *Cureus*. [Clinical Trial Publication]
Hemeryck J (2026). [PMID: 41920533](https://pubmed.ncbi.nlm.nih.gov/41920533/). *JAMA Cardiol*. [Epidemiology / Natural History]